LOS ANGELES–(BUSINESS WIRE)–The University Eye Center Los Angeles, part of Ketchum Health, the clinical teaching facility of Marshall B. Ketchum University (MBKU), is partnering with Walgreens to offer free flu shots to uninsured and underinsured Los…
Category: Business
Wolfspeed Commercially Introduces Transparent Silicon Carbide Technology for Augmented Reality and Quantum Computing
DURHAM, N.C.–(BUSINESS WIRE)–Wolfspeed, Inc. (NYSE: WOLF), a global leader in silicon carbide (SiC) technology, today announced the commercial introduction of its proprietary transparent silicon carbide (TSiC™) technology expanding the potential of s…
OSRX Simplifies Prescription Payments with New AI Phone Assistant
MISSOULA, Mont.–(BUSINESS WIRE)– #ArtificialIntelligence–As artificial intelligence continues to transform healthcare, OSRX, Inc. is applying the technology to a common patient frustration: waiting on hold. The Montana-based ophthalmic compounding p…
OSRX Simplifies Prescription Payments with New AI Phone Assistant
MISSOULA, Mont.–(BUSINESS WIRE)– #ArtificialIntelligence–As artificial intelligence continues to transform healthcare, OSRX, Inc. is applying the technology to a common patient frustration: waiting on hold. The Montana-based ophthalmic compounding p…
Bausch + Lomb Posts Strong Third-Quarter Performance, Raises Full-Year 2026 Guidance
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2026 financial results. “Our third-quarter perfo…
Bausch + Lomb Posts Strong Third-Quarter Performance, Raises Full-Year 2026 Guidance
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2026 financial results. “Our third-quarter perfo…
vRad Study Finds Radiologists Miss 40.7% of Superior Mesenteric Artery Occlusions Across 79,163 CT Exams
MINNEAPOLIS–(BUSINESS WIRE)–New research published in Clinical Imaging suggests that superior mesenteric artery occlusion (SMAO), a life-threatening vascular emergency requiring rapid diagnosis and treatment, may be overlooked on CT interpretation mo…
vRad Study Finds Radiologists Miss 40.7% of Superior Mesenteric Artery Occlusions Across 79,163 CT Exams
MINNEAPOLIS–(BUSINESS WIRE)–New research published in Clinical Imaging suggests that superior mesenteric artery occlusion (SMAO), a life-threatening vascular emergency requiring rapid diagnosis and treatment, may be overlooked on CT interpretation mo…
Johnson & Johnson to Host Enterprise Business Review
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will hold an Enterprise Business Review for the investment community on Tuesday, December 8th, 2026. During the event, Company leaders will provide a detailed review of the Innovat…
Johnson & Johnson to Host Enterprise Business Review
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will hold an Enterprise Business Review for the investment community on Tuesday, December 8th, 2026. During the event, Company leaders will provide a detailed review of the Innovat…
Riassunto: Even Realities introduce il classico design tartarugato per gli occhiali smart con il nuovo modello Even G2 Brown 2
NEW YORK–(BUSINESS WIRE)–Even Realities, l’azienda ideatrice di occhiali intelligenti senza fotocamera con priorità al display, ha presentato oggi Brown 2, una nuova colorazione di ispirazione al tartarugato per Even G2, assieme a due accessori: Even…
Samenvatting: Even Realities brengt klassiek schildpadpatroon naar slimme brillen met nieuwe Brown 2-uitvoering van de Even G2
NEW YORK–(BUSINESS WIRE)–Even Realities, het bedrijf achter slimme brillen zonder camera die focussen op een geïntegreerd display, introduceerde vandaag de Brown 2, een nieuwe, op schildpadpatroon geïnspireerde kleurstelling voor de Even G2, naast tw…
Resumen: Even Realities lleva el clásico diseño de carey a las gafas inteligentes con las nuevas Even G2 Brown 2
NUEVA YORK–(BUSINESS WIRE)–Even Realities, la empresa que ha creado las gafas inteligentes sin cámara centradas en la pantalla, ha presentado hoy el modelo Brown 2, una nueva variante de color inspirada en el carey clásico para las Even G2, junto con…
Even Realities adopte le motif classique « écaille de tortue » pour ses lunettes connectées avec le nouveau modèle Even G2 Brown 2
NEW YORK–(BUSINESS WIRE)–Even Realities, la société à l’origine des lunettes connectées sans caméra qui privilégient l’affichage d’informations, a dévoilé aujourd’hui Brown 2, une nouvelle déclinaison des Even G2 inspirée du motif écaille de tortue, …
Even Realities bringt mit dem neuen Modell „Even G2 Brown 2“ das klassische Schildpatt-Design auf Smart-Brillen
NEW YORK–(BUSINESS WIRE)–Even Realities, das Unternehmen hinter den kameralosen, displayorientierten Smart-Brillen, hat heute „Brown 2“ vorgestellt, eine neue, von Schildpatt inspirierte Farbvariante für die Even G2, sowie zwei Accessoires: den Even …
Even Realities Brings Classic Tortoiseshell Design to Smart Glasses with New Even G2 Brown 2
NEW YORK–(BUSINESS WIRE)–Even Realities, the company behind camera-free, display-first smart glasses, today introduced Brown 2, a new tortoiseshell-inspired colorway for Even G2, alongside two accessories: Even G2 Clip (Polarized) and the Even G2 Cha…
FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
GENEVA–(BUSINESS WIRE)–FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
FDA Approves Genentech’s Enspryng, a First-in-Class IL-6R Inhibitor, as the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $RHHBY–Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Enspryng® (satralizumab-mwge) for the treatment …
Warby Parker to Announce Third Quarter 2026 Financial Results on November 5, 2026
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2026, will be released befor…
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, and its parent company, Bausch Health Companies Inc. (NYSE/TSX: BHC), today announced that Bausch + Lomb Board of Directors Chairman Tho…